Patents
Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
03/2004
03/03/2004EP1392284A2 Methods of treating hyperlipidemia
03/03/2004EP1392283A1 Substituted coumarins and quinolines as caspases activators
03/03/2004EP1045839B1 Novel amines as pharmaceutical agents
03/03/2004CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
02/2004
02/26/2004WO2003006425A9 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
02/26/2004US20040038977 Treating arthritis, pain and cancer
02/25/2004EP1390344A2 Organic compounds
02/25/2004CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same
02/24/2004CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
02/19/2004US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin
02/19/2004US20040033317 Surface-active photoinitators
02/17/2004US6692657 Alkenyl compound with 2,3-difluorophenyl group
02/12/2004US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
02/11/2004CN1474803A Novel amide derivatives and medicinal use thereof
02/05/2004WO2004011557A1 Functional fluorescent dyes
02/05/2004WO2003074475A3 Substituted aryl ketones
02/04/2004CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them
02/03/2004US6686350 Cell adhesion inhibitors
01/2004
01/29/2004WO2004009577A1 Heterodiamondoids
01/29/2004US20040016906 Difluoromethyl ether derivative and process for producing the same
01/29/2004US20040016370 Coatings, films, circuit board
01/29/2004CA2492857A1 Heterodiamondoids
01/28/2004CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
01/27/2004US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives
01/27/2004US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
01/27/2004US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms
01/22/2004WO2004007531A2 Activated checkpoint therapy and methods of use thereof
01/22/2004US20040014988 Salt formation with lithium hydroxide in a solvent mixture, comprises aromatic hydrocarbon toluene and methanol, improving filtration, separation
01/22/2004CA2492772A1 Activated checkpoint therapy and methods of use thereof
01/15/2004WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
01/15/2004US20040010143 Viricides
01/15/2004US20040009999 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
01/14/2004EP1380580A1 An improved process for the production of subsituted thioxanthones
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/13/2004US6677460 Aromatic carboxylic acid bicyclic sulfur compounds
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease
01/08/2004US20040004207 Difluoromethyl ether derivative and process for producing the same
01/06/2004US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
01/02/2004EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
01/02/2004EP1373195A2 Quaternary amino acids on solid supports
01/01/2004US20040002528 CBI analogs of CC-1065 and the duocarmycins
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040002123 Detection of transmembrane potentials by optical methods
12/2003
12/31/2003WO2004000889A2 Polymeric photoinitiators
12/31/2003WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
12/31/2003CN1132831C 液体噻吨酮光引发剂 Liquid thioxanthone photoinitiators
12/31/2003CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
12/30/2003US6670358 Substituted thioacetamides
12/25/2003US20030236425 Ultraviolet radiation curable hot melt pressure sensitive adhesives, coatings and casings
12/25/2003US20030236421 Aromatic carboxylic acid bicyclic sulfur compounds
12/25/2003US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones
12/25/2003US20030236253 Gabapentin; antiepileptic agents, analgesics
12/25/2003US20030236167 Novel herbicides
12/25/2003US20030235779 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method
12/24/2003CN1131855C 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/18/2003US20030232844 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2 mediated disorders
12/11/2003WO2002092552A3 Benzamidoacetonitriles and their use as antiparasitics
12/11/2003US20030229233 Process for the preparation of thioxanthones
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003CN1461302A Friedel-craft process for preparation of thioxanthones
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
11/2003
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/19/2003EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/13/2003US20030212061 Aza-thioxanthenones with antitumor activity
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/11/2003US6645951 Benzopyran or thiobenzopyran derivatives
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003091189A1 Cannabinoids
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003US20030207201 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483072A1 Cannabinoids
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
10/2003
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/29/2003EP1089964B1 Hydrazine derivatives
10/28/2003US6638685 Resolution, sensitivity and smoothness on side surfaces of a transferred pattern; photolithography
10/23/2003WO2002046128A3 Quaternary amino acids on solid supports
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030198889 Sulfonium salt compounds represented by the following general formula (2) wherein R1 and R2 represent each an alkyl group optionally having oxo, or R1 and R2 may be cyclized together to form an alkylene group optionally having oxo group for
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 48